These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
221 related articles for article (PubMed ID: 6148792)
61. More data on supersensitivity psychosis. Witschy JK; Malone GL; Holden LD Am J Psychiatry; 1984 Oct; 141(10):1302. PubMed ID: 6148896 [No Abstract] [Full Text] [Related]
62. [Value of clozapine in treatment of psychotic disorder in Parkinson disease]. Abbar M; Courtet P; Castelnau D Encephale; 1996; 22(1):53-63. PubMed ID: 8681876 [TBL] [Abstract][Full Text] [Related]
63. [Neuroleptics and nicotine]. Erdmann R Psychiatr Prax; 1995 Nov; 22(6):223-7. PubMed ID: 8570751 [TBL] [Abstract][Full Text] [Related]
69. Are there any reports of organic brain syndrome resulting from concomitant use of phenothiazines and anti-Parkinsonian agents? N Y State J Med; 1973 Dec; 73(24):2898-9. PubMed ID: 4520043 [No Abstract] [Full Text] [Related]
70. Treatment of clozapine-associated tardive dyskinesia. Lin CC; Bai YM; Chen JY; Wang YC; Liou YJ Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb; 32(2):599-600. PubMed ID: 17920744 [No Abstract] [Full Text] [Related]
71. [Antagonism between anti-Parkinson drugs and neuroleptics. Apropos of various withdrawal experiences, a personal one among them (2nd part)]. Bourgeois M; Bouey P Ann Med Psychol (Paris); 1976 Nov; 2(4):669-708. PubMed ID: 1020864 [No Abstract] [Full Text] [Related]
72. Neuroleptic-induced acute extrapyramidal syndromes and tardive dyskinesia. Casey DE Psychiatr Clin North Am; 1993 Sep; 16(3):589-610. PubMed ID: 8105453 [TBL] [Abstract][Full Text] [Related]
73. Involvement of serotonin in clinical features of Parkinson's disease and complications of L-DOPA therapy. Melamed E; Zoldan J; Friedberg G; Ziv I; Weizmann A Adv Neurol; 1996; 69():545-50. PubMed ID: 8615179 [No Abstract] [Full Text] [Related]